These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16509530)

  • 21. A comprehensive team approach to the management of patients with Prader-Willi syndrome.
    Eiholzer U; Whitman BY
    J Pediatr Endocrinol Metab; 2004 Sep; 17(9):1153-75. PubMed ID: 15506675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome.
    Gondoni LA; Vismara L; Marzullo P; Vettor R; Liuzzi A; Grugni G
    J Endocrinol Invest; 2008 Sep; 31(9):765-72. PubMed ID: 18997487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing physical activity in adult women with Prader-Willi syndrome: A transferability study.
    Bellicha A; Coupaye M; Hocquaux L; Speter F; Oppert JM; Poitou C
    J Appl Res Intellect Disabil; 2020 Mar; 33(2):258-267. PubMed ID: 31578803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
    L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
    Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy.
    Eiholzer U; l'Allemand D; van der Sluis I; Steinert H; Gasser T; Ellis K
    Horm Res; 2000; 53(4):200-6. PubMed ID: 11044804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of a 6-month home-based training program in Prader-Willi patients.
    Vismara L; Cimolin V; Grugni G; Galli M; Parisio C; Sibilia O; Capodaglio P
    Res Dev Disabil; 2010; 31(6):1373-9. PubMed ID: 20667691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Health-Related Outcomes in Youth With Obesity in Response to a Home-Based Parent-Led Physical Activity Program.
    Rubin DA; Wilson KS; Castner DM; Dumont-Driscoll MC
    J Adolesc Health; 2019 Sep; 65(3):323-330. PubMed ID: 30833118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Schroor EJ; Van Alfen AA; Van Leeuwen M; Van Pinxteren-Nagler E; Van Wieringen H; Vreuls RC; Zwaveling-Soonawala N; de Ridder MA; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4013-22. PubMed ID: 24001750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of magnetic resonance imaging to characterize abnormal body composition phenotypes in youth with Prader-Willi syndrome.
    Orsso CE; Mackenzie M; Alberga AS; Sharma AM; Richer L; Rubin DA; Prado CM; Haqq AM
    Metabolism; 2017 Apr; 69():67-75. PubMed ID: 28285653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
    Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
    J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up.
    Schmidt H; Pozza SB; Bonfig W; Schwarz HP; Dokoupil K
    J Pediatr Endocrinol Metab; 2008 Jul; 21(7):651-5. PubMed ID: 18780599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal muscle characteristics and motor performance after 2-year growth hormone treatment in adults with prader-willi syndrome.
    Lafortuna CL; Minocci A; Capodaglio P; Gondoni LA; Sartorio A; Vismara L; Rizzo G; Grugni G
    J Clin Endocrinol Metab; 2014 May; 99(5):1816-24. PubMed ID: 24471571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.
    Carrel AL; Moerchen V; Myers SE; Bekx MT; Whitman BY; Allen DB
    J Pediatr; 2004 Dec; 145(6):744-9. PubMed ID: 15580194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.
    Höybye C; Hilding A; Jacobsson H; Thorén M
    Clin Endocrinol (Oxf); 2003 May; 58(5):653-61. PubMed ID: 12699450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects.
    Butler MG; Theodoro MF; Bittel DC; Donnelly JE
    Am J Med Genet A; 2007 Mar; 143A(5):449-59. PubMed ID: 17103434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased adrenal androgen levels in patients with Prader-Willi syndrome are associated with insulin, IGF-I, and leptin, but not with measures of obesity.
    L'Allemand D; Eiholzer U; Rousson V; Girard J; Blum W; Torresani T; Gasser T
    Horm Res; 2002; 58(5):215-22. PubMed ID: 12401940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.